2seventy bio: Q3 Earnings Insights
Portfolio Pulse from Benzinga Insights
2seventy bio (NASDAQ:TSVT) reported Q3 earnings with an EPS of $-1.0, missing estimates by 3.09% compared to the expected $-0.97. Revenue decreased by $1.37 million from the same period last year. In the previous quarter, the company beat EPS estimates which led to a 4.98% share price increase the following day. Historical earnings and revenue figures were also provided for comparison.
November 14, 2023 | 12:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
2seventy bio reported lower than expected Q3 earnings and a decrease in revenue compared to last year, which may negatively impact investor sentiment and the stock price in the short term.
Missing earnings estimates typically results in negative investor sentiment, potentially leading to a decrease in stock price. The historical context of a previous earnings beat resulting in a stock price increase suggests that the market is responsive to 2seventy bio's earnings reports. However, the impact may be somewhat mitigated by the relatively small miss in EPS.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100